Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 108
Filter
1.
Adv Mater ; : e2405505, 2024 May 20.
Article in English | MEDLINE | ID: mdl-38767502

ABSTRACT

4D printing is an emerging field where 3D printing techniques are used to pattern stimuli-responsive materials to create morphing structures, with time serving as the fourth dimension. However, current materials utilized for 4D printing are typically soft, exhibiting an elastic modulus (E) range of 10-4 to 10 MPa during shape change. This restricts the scalability, actuation stress, and load-bearing capabilities of the resulting structures. To overcome these limitations, multiscale heterogeneous polymer composites are introduced as a novel category of stiff, thermally responsive 4D printed materials. These inks exhibit an E that is four orders of magnitude greater than that of existing 4D printed materials and offer tunable electrical conductivities for simultaneous Joule heating actuation and self-sensing capabilities. Utilizing electrically controllable bilayers as building blocks, a flat geometry is designed and printed that morphs into a 3D self-standing lifting robot, setting new records for weight-normalized load lifted and actuation stress when compared to other 3D printed actuators. Furthermore, the ink palette is employed to create and print planar lattice structures that transform into various self-supporting complex 3D shapes. These contributions are integrated into a 4D printed electrically controlled multigait crawling robotic lattice structure that can carry 144 times its own weight.

2.
World J Hepatol ; 16(3): 452-464, 2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38577539

ABSTRACT

BACKGROUND: A new nomenclature consensus has emerged for liver diseases that were previously known as non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD). They are now defined as metabolic dysfunction-associated steatotic liver disease (MASLD), which includes cardiometabolic criteria in adults. This condition, extensively studied in obese or overweight patients, constitutes around 30% of the population, with a steady increase worldwide. Lean patients account for approximately 10%-15% of the MASLD population. However, the pathogenesis is complex and is not well understood. AIM: To systematically review the literature on the diagnosis, pathogenesis, characteristics, and prognosis in lean MASLD patients and provide an interpretation of these new criteria. METHODS: We conducted a comprehensive database search on PubMed and Google Scholar between January 2012 and September 2023, specifically focusing on lean NAFLD, MAFLD, or MASLD patients. We include original articles with patients aged 18 years or older, with a lean body mass index categorized according to the World Health Organization criteria, using a cutoff of 25 kg/m2 for the general population and 23 kg/m2 for the Asian population. RESULTS: We include 85 studies in our analysis. Our findings revealed that, for lean NAFLD patients, the prevalence rate varied widely, ranging from 3.8% to 34.1%. The precise pathogenesis mechanism remained elusive, with associations found in genetic variants, epigenetic modifications, and adaptative metabolic response. Common risk factors included metabolic syndrome, hypertension, and type 2 diabetes mellitus, but their prevalence varied based on the comparison group involving lean patients. Regarding non-invasive tools, Fibrosis-4 index outperformed the NAFLD fibrosis score in lean patients. Lifestyle modifications aided in reducing hepatic steatosis and improving cardiometabolic profiles, with some medications showing efficacy to a lesser extent. However, lean NAFLD patients exhibited a worse prognosis compared to the obese or overweight counterpart. CONCLUSION: MASLD is a complex disease comprising epigenetic, genetic, and metabolic factors in its pathogenesis. Results vary across populations, gender, and age. Limited data exists on clinical practice guidelines for lean patients. Future studies employing this new nomenclature can contribute to standardizing and generalizing results among lean patients with steatotic liver disease.

3.
Adv Mater ; 36(8): e2307858, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38063841

ABSTRACT

4D printing is an emerging field where 3D printing techniques are used to pattern stimuli-responsive materials to create morphing structures, with time serving as the fourth dimension. However, current materials utilized for 4D printing are typically soft, exhibiting an elastic modulus (E) range of 10-4 to 10 MPa during shape change. This restricts the scalability, actuation stress, and load-bearing capabilities of the resulting structures. To overcome these limitations, multiscale heterogeneous polymer composites are introduced as a novel category of stiff, thermally responsive 4D printed materials. These inks exhibit an E that is four orders of magnitude greater than that of existing 4D printed materials and offer tunable electrical conductivities for simultaneous Joule heating actuation and self-sensing capabilities. Utilizing electrically controllable bilayers as building blocks, a flat geometry that morphs into a 3D self-standing lifting robot is designed and printed, setting new records for weight-normalized load lifted and actuation stress when compared to other 3D printed actuators. Furthermore, this ink palette is employed to create and print planar lattice structures that transform into various self-supporting complex 3D shapes. Finally these inks are integrated into a 4D printed electrically controlled multigait crawling robotic lattice structure that can carry 144 times its own weight.

4.
Ann Hepatol ; 29(2): 101181, 2024.
Article in English | MEDLINE | ID: mdl-37981236

ABSTRACT

INTRODUCTION AND OBJECTIVES: Tolloid like protein 1 (TLL1) rs17047200 has been reported to be associated with HCC development and liver fibrosis. However, to our knowledge, no studies have been performed on Latin Americans and comparative differences between TLL1 rs17047200 in HCC patients from Latin America and Europe are undefined. MATERIALS AND METHODS: Cross-sectional analysis was performed on Latin American and European individuals. We analyzed TLL1 rs17047200 on DNA from 1194 individuals, including 420 patients with HCC (86.0 % cirrhotics) and 774 without HCC (65.9 % cirrhotics). RESULTS: TLL1 rs17047200 genotype AT/TT was not associated with HCC development in Latin Americans (OR: 0.699, 95 %CI 0.456-1.072, p = 0.101) or Europeans (OR: 0.736, 95 %CI 0.447-1.211, p = 0.228). TLL1 AT/TT was not correlated with fibrosis stages among metabolic dysfunction-associated steatotic liver disease (MASLD) patients from Latin America (OR: 0.975, 95 %CI 0.496-1.918, p = 0.941). Among Europeans, alcohol-related HCC had lower TLL1 AT/TT frequencies than cirrhosis (18.3 % versus 42.3 %, OR: 0.273, 95 %CI 0.096-0.773, p = 0.015). CONCLUSIONS: We found no evidence that the TLL1 rs17047200 AT/TT genotype is a risk factor for HCC development in Latin Americans or Europeans. A larger study integrating ethnic and etiology backgrounds is needed to determine the importance of the TLL1 SNP in HCC development.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/genetics , Cross-Sectional Studies , Liver Cirrhosis/diagnosis , Liver Cirrhosis/epidemiology , Liver Cirrhosis/genetics , Liver Neoplasms/epidemiology , Liver Neoplasms/genetics , Liver Neoplasms/complications , Polymorphism, Single Nucleotide , Risk Factors , Tolloid-Like Metalloproteinases/genetics
5.
Lancet Reg Health Am ; 28: 100633, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38058662

ABSTRACT

Healthcare systems in Latin America are broadly heterogeneous, but all of them are burdened by a dramatic rise in liver disease. Some challenges that these countries face include an increase in patients requiring a transplant, insufficient rates of organ donation, delayed referral, and inequitable or suboptimal access to liver transplant programs and post-transplant care. This could be improved by expanding the donor pool through the implementation of education programs for citizens and referring physicians, as well as the inclusion of extended criteria donors, living donors and split liver transplantation. Addressing these shortcomings will require national shifts aimed at improving infrastructure, increasing awareness of organ donation, training medical personnel, and providing equitable access to care for all patients.

6.
Dig Dis Sci ; 68(11): 4212-4220, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37684433

ABSTRACT

BACKGROUND: The rs641738 C > T single-nucleotide polymorphism of MBOAT7 has been associated with hepatocellular carcinoma (HCC) and nonalcoholic fatty liver disease (NAFLD). Latin Americans have high rates of HCC and NAFLD, but no assessment between MBOAT7 and HCC has been performed in this population. AIMS: We provide the first assessment of the impact of MBOAT7 on HCC risk in Latin Americans. METHODS: Patients were prospectively recruited into the ESCALON network, designed to collect samples from Latin American patients with HCC in 6 South American countries (Argentina, Ecuador, Brazil, Chile, Peru, and Colombia). A European cohort and the general Hispanic population of gnomAD database were included for comparison. Associations between HCC and MBOAT7 were evaluated using logistic regression. RESULTS: In total, 310 cases of HCC and 493 cases of cirrhosis without HCC were assessed. The MBOAT7 TT genotype was not predictive of HCC in Latin Americans (TT vs CC OR adjusted = 1.15, 95% CI 0.66-2.01, p = 0.610) or Europeans (TT vs CC OR adjusted = 1.20, 95% CI 0.59-2.43, p = 0.621). No significant association was noted on subgroup analysis for NAFLD, viral hepatitis, or alcohol-related liver disease. The TT genotype was increased in the NAFLD-cirrhosis cohort of Latin Americans compared to a non-cirrhotic NAFLD cohort (TT vs CC + CT OR = 2.75, 95% CI 1.10-6.87, p = 0.031). CONCLUSION: The rs631738 C > T allele of MBOAT7 was not associated with increased risk of HCC in Latin Americans or Europeans. An increase in the risk of cirrhosis was noted with the TT genotype in Latin Americans with NAFLD.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Non-alcoholic Fatty Liver Disease , Humans , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/complications , Non-alcoholic Fatty Liver Disease/pathology , Latin America/epidemiology , Genetic Predisposition to Disease , Liver Neoplasms/epidemiology , Liver Neoplasms/genetics , Liver Neoplasms/complications , Acyltransferases/genetics , Liver Cirrhosis/complications , Polymorphism, Single Nucleotide , Fibrosis , Membrane Proteins/genetics
7.
Cancers (Basel) ; 15(18)2023 Sep 12.
Article in English | MEDLINE | ID: mdl-37760499

ABSTRACT

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. The STAT4 rs7574865 genetic variant has been associated with an increased risk of developing HCC in Asian populations. However, this association has not been studied in Latin America and is poorly assessed in European populations. This case-control study investigated the association between STAT4 rs7574865 and HCC risk in these populations. We evaluated DNA samples from seven medical institutions across six Latin American countries and one Dutch institution in 1060 individuals (344 HCC and 716 controls). STAT4 rs7574865 SNP was genotyped using TaqMan-genotyping assay and analyzed using logistic regression. We found no significant association between the homozygous risk allele (G) of STAT4 and HCC development in either population, with odds ratios (OR) for GG versus TT of 0.85 (CI: 0.48-1.52, p = 0.58) and 0.81 (CI: 0.34-1.93, p = 0.67) for Latin Americans and Europeans respectively. No correlation was found between the risk allele and HCC based on underlying liver disease. However, we found that Latin Americans of European ancestry were more likely to carry the risk allele. Our results suggest that the STAT4 SNP rs7574865 does not influence the risk of developing HCC in Latin American or European populations, highlighting the importance of evaluating genetic risk factors in various ethnic groups and understanding the possible influence of ancestry on the genetic basis of disease.

8.
Aliment Pharmacol Ther ; 58(5): 526-536, 2023 09.
Article in English | MEDLINE | ID: mdl-37349900

ABSTRACT

BACKGROUND: The burden of non-alcoholic fatty liver disease (NAFLD) in South America is among the highest in the world. However, the epidemiology and risk factors for NAFLD are insufficiently described in the region. AIM: To explore the associations between clinical characteristics and histopathological features of NAFLD METHODS: This was a descriptive study of 2722 patients with NAFLD from 8 medical centres across 5 South American countries. We collected clinical, biochemical and histopathological data using a templated chart. Fibrosis was assessed by elastography or fibrosis scores and confirmed with biopsy when available. We examined associations between histopathological features and clinical characteristics with logistic regression models. Models were adjusted for country, age and sex. RESULTS: The median age was 53 years (IQR: 41-62), and 63% were women. Subjects from Brazil had the highest body mass index at 42 kg/m2 . Sixty-seven percent had dyslipidemia, 46% had obesity, 30% had hypertension, 17% had type 2 diabetes mellitus (T2DM) and 34% had metabolic syndrome. Biopsy reports were available for 948 (35%), of which 58% showed fibrosis, 91% steatosis and 65% inflammation; 25% showed significant fibrosis and 27% severe steatosis. Metabolic syndrome, T2DM and hypertension were significantly associated with significant fibrosis (OR = 1.94, p < 0.001; OR = 2.93, p < 0.001 and OR = 1.60, p = 0.003, respectively), severe steatosis (OR = 2.05, p < 0.001; OR = 1.91, p = 0.001 and OR = 2.17, p < 0.001, respectively) and liver inflammation (OR = 1.66, p = 0.007; OR = 2.00, p = 0.002; OR = 1.62, p = 0.001, respectively). CONCLUSIONS: In the largest NAFLD cohort study to date from South America, metabolic syndrome, hypertension and T2DM were independently associated with significant fibrosis, severe steatosis, and inflammation. The prevalence of T2DM was lower than the reported global prevalence.


Subject(s)
Diabetes Mellitus, Type 2 , Hypertension , Metabolic Syndrome , Non-alcoholic Fatty Liver Disease , Humans , Female , Middle Aged , Male , Non-alcoholic Fatty Liver Disease/pathology , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/complications , Metabolic Syndrome/epidemiology , Metabolic Syndrome/complications , Cohort Studies , Risk Factors , Liver Cirrhosis/complications , South America/epidemiology , Inflammation/complications , Hypertension/epidemiology , Hypertension/complications , Liver/pathology
10.
Chem Mater ; 35(9): 3522-3531, 2023 May 09.
Article in English | MEDLINE | ID: mdl-37181669

ABSTRACT

Nanoparticles (NPs) of conjugated polymers in intimate contact with sheets of graphene oxide (GO) constitute a promising class of water-dispersible nanohybrid materials of increased interest for the design of sustainable and improved optoelectronic thin-film devices, revealing properties exclusively pre-established upon their liquid-phase synthesis. In this context, we report for the first time the preparation of a P3HTNPs-GO nanohybrid employing a miniemulsion synthesis approach, whereby GO sheets dispersed in the aqueous phase serve as a surfactant. We show that this process uniquely favors a quinoid-like conformation of the P3HT chains of the resulting NPs well located onto individual GO sheets. The accompanied change in the electronic behavior of these P3HTNPs, consistently confirmed by the photoluminescence and Raman response of the hybrid in the liquid and solid states, respectively, as well as by the properties of the surface potential of isolated individual P3HTNPs-GO nano-objects, facilitates unprecedented charge transfer interactions between the two constituents. While the electrochemical performance of nanohybrid films is featured by fast charge transfer processes, compared to those taking place in pure P3HTNPs films, the loss of electrochromic effects in P3HTNPs-GO films additionally indicates the unusual suppression of polaronic charge transport processes typically encountered in P3HT. Thus, the established interface interactions in the P3HTNPs-GO hybrid enable a direct and highly efficient charge extraction channel via GO sheets. These findings are of relevance for the sustainable design of novel high-performance optoelectronic device structures based on water-dispersible conjugated polymer nanoparticles.

11.
Res Vet Sci ; 159: 26-34, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37062229

ABSTRACT

Lactating cows can react to changes in nutrient availability with a range of behavioural and physiological mechanisms, which may differ among lactation stages. We investigated the effects of short feed restriction and refeeding periods on beef cows' performance and metabolic status in different months of lactation. For this, Parda de Montaña beef cows [n = 31; 626 ± 47.7 kg body weight (BW)] were subjected to short nutritional restriction and refeeding cycles, which were repeated in months 2, 3 and 4 of lactation. Each month, cows were consecutively fed a diet to meet 100% of their energy and protein requirements during a 4-day basal period, 55% during a 4-day restriction period, and again 100% during a 4-day refeeding period. The performance (energy balance, BW, milk yield and composition) and plasma metabolite concentrations (glucose, non-esterified fatty acids (NEFA), ß-hydroxybutyrate (BHB), urea and malondialdehyde) were measured daily. Most of the traits were significantly affected by the interaction between feeding period and lactation month. Feed restriction induced milk yield loss, decreased milk protein and increased milk urea contents to different extents. The plasma NEFA concentrations rose with restriction in months 2, 3 and 4 but BHB and urea concentrations increased only in month 4. Most of these metabolites lowered to basal values during refeeding. These results suggest that beef cows use different adaptation strategies to cope with nutritional challenges as lactation advances, body fat mobilisation predominates in early lactation and protein catabolism prevails at later stages.


Subject(s)
Fatty Acids, Nonesterified , Lactation , Female , Cattle , Animals , Lactation/physiology , Milk/metabolism , Diet/veterinary , Body Weight , Urea , Energy Metabolism/physiology , Animal Feed/analysis , 3-Hydroxybutyric Acid
13.
J Anim Sci ; 1012023 Jan 03.
Article in English | MEDLINE | ID: mdl-36795068

ABSTRACT

Our study objective was to determine the effect of a short feed restriction (4 d) and subsequent refeeding (4 d) on the performance and metabolism of beef cows with a different nutritional status by particularly focusing on their milk fatty acid (FA) profile, to consider its potential use as biomarker of metabolic status. Thirty-two Parda de Montaña multiparous lactating beef cows were individually fed a diet based on the average cow's net energy (NE) and metabolizable protein requirements. At 58 d in milk (DIM, day 0), cows underwent a 4 d feed restriction (55% requirements, restriction period). Before and after the restriction, diets met 100% of their requirements (basal and refeeding periods). Cow performance, milk yield and composition, and plasma metabolites, were determined on day -2, 1, 3, 5, 6, and 8. Cows were classified into two status clusters according to their pre-challenge performance and energy balance (EB) (Balanced vs. Imbalanced). All traits were statistically analyzed considering the fixed effect of status cluster and feeding period or day, with cow as a random effect. Imbalanced cows were heavier and had a more negative EB (P < 0.001), but similar milk yield, milk composition, and circulating metabolites (except for greater urea) than Balanced cows (P > 0.10). Milk contents of C18:1 cis-9, monounsaturated FA (MUFA), and mobilization FA were greater (P < 0.05), whereas saturated FA (SFA) and de novo FA were lesser in Imbalanced than Balanced cows (P < 0.05). Restriction decreased body weight (BW), milk yield, and milk protein compared to the basal period, but increased milk urea and plasma nonesterified fatty acids (NEFA) (P < 0.001). Milk contents of SFA, de novo, and mixed FA decreased immediately during the restriction, while MUFA, polyunsaturated FA and mobilization FA increased (P < 0.001). Basal milk FA contents were recovered on day 2 of refeeding, and all their changes strongly correlated with differences in EB and NEFA (P < 0.05). The general lack of interactions between status clusters and feeding periods implied that the response mechanisms to diet changes did not differ between cows with a different pre-challenge nutritional status.


Lactating cows can undergo periods with a negative energy balance due to feed shortages, which trigger metabolic adaptations to support cow maintenance and milk yield. We explored beef cows' response to a short feed restriction (4 d, 55% of their energy and protein requirements) and subsequent refeeding (4 d, 100% of their energy and protein requirements) in the second month of lactation. We analyzed the effect on their performance and metabolism by placing special emphasis on milk production and milk fatty acid composition in two beef cow groups with a different nutritional status before the challenge. When cows faced a food restriction, both groups had similar changes in productive and metabolic traits. These changes are similar to those occurring in restricted dairy cows, but of lesser magnitude due to the lower milk yield and associated metabolic load of beef cows. The milk fatty acid profile, rarely analyzed in beef cows, proved to be an accurate indicator of their metabolic status.


Subject(s)
Fatty Acids , Lactation , Female , Cattle , Animals , Fatty Acids/metabolism , Fatty Acids, Nonesterified , Dietary Supplements , Diet/veterinary , Nutrients , Urea/pharmacology , Animal Feed/analysis , Energy Metabolism
14.
ChemSusChem ; 16(8): e202202322, 2023 Apr 21.
Article in English | MEDLINE | ID: mdl-36629277

ABSTRACT

Covalent functionalization of tungsten disulfide (WS2 ) with photo- and electro-active nickel-porphyrin (NiP) is reported. Exfoliated WS2 interfacing NiP moieties with 1,2-dithiolane linkages is assayed in the oxygen evolution reaction under both dark and illuminated conditions. The hybrid material presented, WS2 -NiP, is fully characterized with complementary spectroscopic, microscopic, and thermal techniques. Standard yet advanced electrochemical techniques, such as linear sweep voltammetry, electrochemical impedance spectroscopy, and calculation of the electrochemically active surface area, are used to delineate the catalytic profile of WS2 -NiP. In-depth study of thin films with transient photocurrent and photovoltage response assays uncovers photo-enhanced electrocatalytic behavior. The observed photo-enhanced electrocatalytic activity of WS2 -NiP is attributed to the presence of Ni centers coordinated and stabilized by the N4 motifs of tetrapyrrole rings at the tethered porphyrin derivative chains, which work as photoreceptors. This pioneering work opens wide routes for water oxidation, further contributing to the development of non-noble metal electrocatalysts.

16.
Nucleic Acids Res ; 51(D1): D1353-D1359, 2023 Jan 06.
Article in English | MEDLINE | ID: mdl-36399499

ABSTRACT

The Open Targets Platform (https://platform.opentargets.org/) is an open source resource to systematically assist drug target identification and prioritisation using publicly available data. Since our last update, we have reimagined, redesigned, and rebuilt the Platform in order to streamline data integration and harmonisation, expand the ways in which users can explore the data, and improve the user experience. The gene-disease causal evidence has been enhanced and expanded to better capture disease causality across rare, common, and somatic diseases. For target and drug annotations, we have incorporated new features that help assess target safety and tractability, including genetic constraint, PROTACtability assessments, and AlphaFold structure predictions. We have also introduced new machine learning applications for knowledge extraction from the published literature, clinical trial information, and drug labels. The new technologies and frameworks introduced since the last update will ease the introduction of new features and the creation of separate instances of the Platform adapted to user requirements. Our new Community forum, expanded training materials, and outreach programme support our users in a range of use cases.

17.
Ann Hepatol ; 28(2): 100876, 2023.
Article in English | MEDLINE | ID: mdl-36400386

ABSTRACT

INTRODUCTION AND OBJECTIVES: Most epidemiological data on hepatocellular carcinoma (HCC) originate from resource-rich countries. We have previously described the epidemiology of HCC in South America through the South American Liver Research Network. Here, we provide an update on the changing epidemiology of HCC in the continent seven years since that report. MATERIALS AND METHODS: We evaluated all cases of HCC diagnosed between 2019 to 2021 in centers from six countries in South America. A templated, retrospective chart review of patient characteristics at the time of HCC diagnosis, including basic demographic, clinical and laboratory data, was completed. Diagnosis of HCC was made radiologically or histologically for all cases via institutional standards. RESULTS: Centers contributed to a total of 339 HCC cases. Peru accounted for 37% (n=125) of patients; Brazil 16% (n=57); Chile 15% (n=51); Colombia 14% (n=48); Argentina 9% (n=29); and Ecuador 9% (n=29). The median age at HCC diagnosis was 67 years (IQR 59-73) and 61% were male. The most common risk factor was nonalcoholic fatty liver disease (NAFLD, 37%), followed by hepatitis C (17%), alcohol use disorder (11%) and hepatitis B (12%). The majority of HCCs occurred in the setting of cirrhosis (80%). HBV-related HCC occurred at a younger age compared to other causes, with a median age of 46 years (IQR 36-64). CONCLUSIONS: We report dramatic changes in the epidemiology of HCC in South America over the last decade, with a substantial increase in NAFLD-related HCC. HBV-related HCC still occurs at a much younger age when compared to other causes.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Non-alcoholic Fatty Liver Disease , Humans , Male , Adult , Middle Aged , Female , Carcinoma, Hepatocellular/diagnosis , Liver Neoplasms/diagnosis , Non-alcoholic Fatty Liver Disease/diagnosis , Non-alcoholic Fatty Liver Disease/epidemiology , Non-alcoholic Fatty Liver Disease/complications , Retrospective Studies , Risk Factors , Liver Cirrhosis/complications , Brazil
18.
Evol Comput ; 31(1): 31-51, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-35943729

ABSTRACT

In the traffic light scheduling problem, the evaluation of candidate solutions requires the simulation of a process under various (traffic) scenarios. Thus, good solutions should not only achieve good objective function values, but they must be robust (low variance) across all different scenarios. Previous work has shown that combining IRACE with evolutionary operators is effective for this task due to the power of evolutionary operators in numerical optimization. In this article, we further explore the hybridization of evolutionary operators and the elitist iterated racing of IRACE for the simulation-optimization of traffic light programs. We review previous works from the literature to find the evolutionary operators performing the best when facing this problem to propose new hybrid algorithms. We evaluate our approach over a realistic case study derived from the traffic network of Málaga (Spain) with 275 traffic lights that should be scheduled optimally. The experimental analysis reveals that the hybrid algorithm comprising IRACE plus differential evolution offers statistically better results than the other algorithms when the budget of simulations is low. In contrast, IRACE performs better than the hybrids for a high simulations budget, although the optimization time is much longer.


Subject(s)
Algorithms , Hybridization, Genetic , Computer Simulation , Nucleic Acid Hybridization , Spain
19.
Anal Chim Acta ; 1205: 339782, 2022 May 01.
Article in English | MEDLINE | ID: mdl-35414388

ABSTRACT

Some inborn errors of metabolism and other diseases can result in increasing blood ammonium (hyperammonemia episodes), which can cause serious neurological complications in patients or even death. Early diagnosis, follow up and treatment are essential to minimize irreversible damages in brain. Currently, adequate analytical instrumentation for the necessary ammonium bedside determination is not available in all health centers but only in clinical laboratories of reference hospitals. We therefore have developed a low cost and portable potentiometric Point-of-Care microanalyzer (POC) to address this problem. It consists of a cyclic olefin copolymer-based microanalyzer, the size of a credit card and working in continuous flow, which integrates microfluidics, a gas-diffusion module and a potentiometric detection system. The analytical features achieved are a linear range from 30 to 1000 µmol L-1 NH4+, a detection limit of 18 µmol L-1 NH4+ and a required sample volume of 100 µL, which comply with the medical requirements. Plasma and blood samples are analyzed with no significant differences observed between ammonium concentrations obtained with both the proposed microanalyzer and the reference method. This demonstrates the value of the developed POC for bedside clinical applications.


Subject(s)
Ammonium Compounds , Cycloparaffins , Humans , Microfluidics , Point-of-Care Systems , Potentiometry
20.
Front Physiol ; 13: 1104327, 2022.
Article in English | MEDLINE | ID: mdl-36714312

ABSTRACT

Background: Characterization of atrial myocardial infarction is hampered by the frequent concurrence of ventricular infarction. Theoretically, atrial infarct scarring could be recognized by multifrequency tissue impedance, like in ventricular infarction, but this remains to be proven. Objective: This study aimed at developing a model of atrial infarction to assess the potential of multifrequency impedance to recognize areas of atrial infarct scar. Methods: Seven anesthetized pigs were submitted to transcatheter occlusion of atrial coronary branches arising from the left coronary circumflex artery. Six weeks later the animals were anesthetized and underwent atrial voltage mapping and multifrequency impedance recordings. The hearts were thereafter extracted for anatomopathological study. Two additional pigs not submitted to atrial branch occlusion were used as controls. Results: Selective occlusion of the atrial branches induced areas of healed infarction in the left atrium in 6 of the 7 cases. Endocardial mapping of the left atrium showed reduced multi-frequency impedance (Phase angle at 307 kHz: from -17.1° ± 5.0° to -8.9° ± 2.6°, p < .01) and low-voltage of bipolar electrograms (.2 ± 0.1 mV vs. 1.9 ± 1.5 mV vs., p < .01) in areas affected by the infarction. Data variability of the impedance phase angle was lower than that of bipolar voltage (coefficient of variability of phase angle at307 kHz vs. bipolar voltage: .30 vs. .77). Histological analysis excluded the presence of ventricular infarction. Conclusion: Selective occlusion of atrial coronary branches permits to set up a model of selective atrial infarction. Atrial multifrequency impedance mapping allowed recognition of atrial infarct scarring with lesser data variability than local bipolar voltage mapping. Our model may have potential applicability on the study of atrial arrhythmia mechanisms.

SELECTION OF CITATIONS
SEARCH DETAIL
...